Customer Appreciation Sale.
15% off with promo code "APPRECIATION2023" on check out or purchase order
- Lu Luo, .et al. Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NF κB/NLRP3 signaling pathway in cerebral ischemic mice, J Neuroinflammation, 2022, Jun 11;19(1):141 PMID: 35690810
- Sarah R Anderson,, .et al. Neuronal apoptosis drives remodeling states of microglia and shifts in survival pathway dependence, bioRxiv, 2022, 01.05.475126
- Hannah D Mason, .et al. Glia limitans superficialis oxidation and breakdown promotes cortical cell death after repeat head injury, JCI Insight, 2021, Oct 8;6(19):e149229 PMID: 34428178
- Chritica Lodder, .et al. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia, Acta Neuropathol Commun, 2021, Jun 8;9(1):108 PMID: 34103079
- Anderson SR, .et al. Developmental Apoptosis Promotes a Disease-Related Gene Signature and Independence from CSF1R Signaling in Retinal Microglia, Cell Rep, 2019, May 14;27(7):2002-2013.e5 PMID: 31091440
Biological Activity
Pexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
Targets
Kit | CSF-1R | Flt3 | ||
10 nM | 20 nM | 160 nM |
In vitro (25°C) | DMSO | 71 mg/mL (169.93 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+45% PEG 300+5% Tween 80+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.93 mL | 119.67 mL | 239.34 mL |
0.5 mM | 4.79 mL | 23.93 mL | 47.87 mL |
1 mM | 2.39 mL | 11.97 mL | 23.93 mL |
5 mM | 0.48 mL | 2.39 mL | 4.79 mL |
*The above data is based on the productmolecular weight 417.81. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A15520 |
---|---|
Actions | Inhibitor |
CAS No. | 1029044-16-3 |
Formula | C20H15ClF3N5 |
M. Wt | 417.81 |
Purity | >98% |
Synonyms | PLX-3397, PLX 3397 |
SMILES | FC(C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C43)C=C2)C=N1)(F)F |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
AZD1480
AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
AZD 2932
AZD2932 is a potent and mutil-targeted protein tyrosine kinase inhibitor with IC50 of 8 nM, 4 nM, 7 nM, and 9 nM for VEGFR-2, PDGFRβ, Flt-3…
AZ-960
AZ-960 is a potent, selective and ATP competitive JAK2 inhibitor that inhibits JAK2 kinase with a Ki of 0.45 nM in vitro and induces growth …
INCB018424 (Ruxolitinib)
INCB018424 is a potent and selective inhibitor of Janus-associated kinase (JAK) 1 and 2, with IC50 to be 2.7, 4.5 and 332 nM for JAK1, JAK2 …
CEP33779
CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM.
Cyt387 (Momelotinib)
CYT387 is an inhibitor of Janus kinases JAK1 and JAK2, acting as an ATP competitor with IC50 values of 11 and 18 nM, respectively.
FLLL32
FLLL32 is a potent JAK2/STAT3 inhibitor with IC50 of
TCS 359
TCS 359 is a potent inhibitor of FLT3 receptor tyrosine kinase (IC50 = 42 nM) that displays selectivity over a range of other kinases.
Keywords:buy Pexidartinib (PLX3397) | Pexidartinib (PLX3397) Supplier | purchase | cost | manufacturer | order | distributor | buy 1029044-16-3| 1029044-16-3 Supplier | purchase 1029044-16-3 | 1029044-16-3 cost | 1029044-16-3 manufacturer | order 1029044-16-3 | 1029044-16-3 distributor